Medical Innovation Inactivates Pathogens in Blood
WATERTOWN, Mass. - Officials at VI Technologies have begun Phase II clinical trails with their INACTINE pathogen reduction red blood cell system - the same system that reportedly can inactive Lyme Disease and West Nile pathogens.
"West Nile virus and the bacterium that causes Lyme disease are prime examples of emerging pathogens," says company president and CEO John R. Barr." Further epidemiologic studies in human transfusion recipients are needed before the transfusion risk, if any, can be ascertained. The results of these studies strengthen the power of the technology - which inactivates an unmatched list of enveloped and non-enveloped viruses, gram negative and gram positive bacteria, parasites and lymphocytes."
Additional information is available at www.vitechnologies.com.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
